Hypogonadism
📧 Sign up to get email alerts when something new happens for Hypogonadism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-02-19FDA Approved: GONAL-F RFF REDI-JECT — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for GONAL-F RFF REDI-JECT (follitropin) by EMD Serono, Inc., adding the REDI-JECT delivery system to…
-
FDA approval · 2013-02-19FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for GONAL-F (follitropin alfa) submitted by EMD Serono, Inc., resulting in an approved update to the…
-
FDA approval · 2013-02-14FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for GONAL-F (follicle-stimulating alfa) submitted by EMD Serono, Inc.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism [Phase 3]
Phase 3 trial evaluating Testogel (testosterone gel 50 mg/5 g) for male hypogonadism; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2013-01-01Clinical Trial Update: Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems [Phase 2]
A Phase 2 study assessing pharmacokinetics, metabolism, efficacy, and safety of two testosterone matrix transdermal systems for hypogonadism…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-12-31Clinical Trial Update: Testosterone Undecanoate and Quality of Life of Men and Spouses
An update on a clinical trial evaluating testosterone undecanoate and quality of life in men with hypogonadism.
-
CLINICAL_TRIALS withdrawal · 2012-11-27Clinical Trial Update: Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks [Phase 4]
A Phase 4 clinical trial comparing Nebido to placebo for late-onset hypogonadism in elderly men has been withdrawn.
-
FDA approval · 2012-11-19FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)
The FDA approved a supplemental application for ANDROGEL (testosterone gel) from ASCEND Therapeutics U.S., LLC.
-
FDA approval · 2012-11-19FDA Approved: TESTOSTERONE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for TESTOSTERONE, submitted by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Effect of Testosterone Replacement on Insulin Resistance [Phase 4]
A Phase 4 trial evaluating the effect of testosterone replacement on insulin resistance in individuals with metabolic syndrome and hypogonad…
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: Epigenetics and Metabolic Disorders in Men With the Klinefelter Syndrome
A completed clinical trial from University Hospital Muenster studied epigenetic factors and metabolic disorders in men with Klinefelter synd…
-
FDA approval · 2012-09-20FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)
The FDA approved a supplemental application for ANDROGEL (testosterone) submitted by ASCEND Therapeutics U.S., LLC.
-
FDA approval · 2012-09-18FDA Approved: TESTOSTERONE ENANTHATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the original ANDA for testosterone enanthate (TESTOSTERONE ENANTHATE) from Hikma Pharmaceuticals USA Inc. as a generic testoste…
-
FDA approval · 2012-09-07FDA Approved: TESTOSTERONE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a testosterone product, enabling its marketing as a generic testosteron…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Cycled Testosterone Replacement Study [Phase 1]
A Phase 1 trial conducted by The University of Texas Medical Branch evaluating cycling testosterone replacement for hypogonadism has complet…
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: TRADE-Testosterone Replacement and Dutasteride Effectiveness [Phase 4]
Phase 4 clinical trial evaluating the effectiveness of testosterone replacement therapy in combination with dutasteride for men with hypogon…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Androgen Deprivation Therapy Study
The National Institute on Aging terminated a clinical trial evaluating androgen deprivation therapy. The study listed hypogonadism, metaboli…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride [Phase 1]
This Phase 1 study evaluates the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutaste…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction [Phase 4]
Phase 4 clinical trial evaluating Nebido (testosterone undecanoate) as monotherapy or with PDE-5 inhibitors for erectile dysfunction in hypo…
-
FDA approval · 2012-05-01FDA Approved: TESTOSTERONE CYPIONATE — Original Application (Padagis US LLC)
FDA approved Padagis US LLC's original Abbreviated New Drug Application (ANDA) for testosterone cypionate, providing a generic option for te…
-
CLINICAL_TRIALS trial_result · 2011-12-22Clinical Trial Update: Quality of Life With TESTIM®
The trial update reports results on quality of life in men with hypogonadism treated with TESTIM, a testosterone gel.
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Testosterone Treatment for Hypogonadal Men [Phase 3]
A Phase 3 trial evaluating testosterone treatment for hypogonadal men has completed, and results were posted on 2011-12-08. The study was sp…
-
FDA approval · 2011-11-22FDA Approved: TESTIM — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for TESTIM (testosterone) from Endo USA, Inc., resulting in an approved change to the product's …
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males. [Phase 1]
This document provides an update on a Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of testosterone undecanoate in…
-
FDA approval · 2011-10-28FDA Approved: CONJUGATED ESTROGENS — Supplemental Application (Prasco Laboratories)
FDA has approved a supplemental NDA for Conjugated Estrogens (Estrogens, Conjugated) from Prasco Laboratories.